Pfizer’s hemophilia therapy reduces bleeding in late-stage study, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

The estimated prevalence in the United States is 12 cases per 100,000 males for hemophilia A and 3.7 cases per 100,000 males for hemophilia B. The current standard of care requires regular infusion of the missing proteins., The estimated prevalence in the United States is 12 cases per 100,000 males for hemophilia A and 3.7 cases per 100,000 males for hemophilia B. The current standard of care requires regular infusion of the missing proteins., , Read More